Clinical Trial Update: Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

View source ↗

Summary

Completed clinical trial evaluating adherence and effectiveness of tofacitinib modified release in rheumatoid arthritis with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• tofacitinib modified release (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2020-04-10